US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.460
  • -0.040-2.67%
Close Nov 22 16:00 ET
37.86MMarket Cap-4866P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.02%-1.69M
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
Net income from continuing operations
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Other non cash items
--59.7K
--151.23K
--59.7K
--59.7K
----
----
----
----
----
----
Change In working capital
135.93%164.13K
-168.64%-799.26K
-62.82%-939.85K
-114.38%-55.17K
-34.21%652.56K
-224.80%-456.8K
28.28%1.16M
-697.96%-577.23K
32.35%383.79K
550.78%991.91K
-Change in receivables
---245.36K
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
196.45%100.85K
-98.53%8.96K
-22.70%-190.11K
-119.59%-51.94K
417.10%355.57K
-124.36%-104.56K
-4.50%608.21K
53.08%-154.95K
4.31%265.11K
-79.64%68.76K
-Change in payables and accrued expense
187.62%308.64K
-245.29%-808.22K
-77.54%-749.74K
-102.73%-3.24K
-67.83%297K
-456.65%-352.24K
105.34%556.27K
-198.95%-422.28K
231.21%118.68K
265.51%923.15K
Cash from discontinued investing activities
Operating cash flow
38.02%-1.69M
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-100.98%-62.35K
0
0
6.38M
-68.16K
0
-248.93K
Net common stock issuance
----
--0
--0
--0
----
----
--6.65M
--0
--0
--0
Proceeds from stock option exercised by employees
----
--0
--0
--0
----
----
--52.4K
--0
--0
--0
Net other financing activities
----
80.34%-62.35K
--0
--0
----
----
---317.08K
---68.16K
--0
----
Cash from discontinued financing activities
Financing cash flow
----
-100.98%-62.35K
--0
--0
----
----
--6.38M
---68.16K
--0
---248.93K
Net cash flow
Beginning cash position
-72.49%3.09M
-22.69%11.25M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-27.21%14.55M
-14.40%14.16M
-9.18%16.36M
0.03%19.21M
Current changes in cash
38.02%-1.69M
-146.99%-8.15M
29.63%-2.05M
31.64%-1.5M
34.37%-1.88M
-158.45%-2.73M
39.29%-3.3M
-45.92%-2.92M
-49.91%-2.19M
-138.44%-2.86M
End cash Position
-83.52%1.4M
-72.49%3.09M
-72.49%3.09M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-22.69%11.25M
-14.40%14.16M
-9.18%16.36M
Free cash flow
38.02%-1.69M
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.02%-1.69M16.44%-8.09M27.95%-2.05M31.64%-1.5M30.49%-1.81M-34.07%-2.73M-78.09%-9.68M-42.52%-2.85M-49.91%-2.19M-117.68%-2.61M
Net income from continuing operations 11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M
Other non cash items --59.7K--151.23K--59.7K--59.7K------------------------
Change In working capital 135.93%164.13K-168.64%-799.26K-62.82%-939.85K-114.38%-55.17K-34.21%652.56K-224.80%-456.8K28.28%1.16M-697.96%-577.23K32.35%383.79K550.78%991.91K
-Change in receivables ---245.36K------------------0----------------
-Change in prepaid assets 196.45%100.85K-98.53%8.96K-22.70%-190.11K-119.59%-51.94K417.10%355.57K-124.36%-104.56K-4.50%608.21K53.08%-154.95K4.31%265.11K-79.64%68.76K
-Change in payables and accrued expense 187.62%308.64K-245.29%-808.22K-77.54%-749.74K-102.73%-3.24K-67.83%297K-456.65%-352.24K105.34%556.27K-198.95%-422.28K231.21%118.68K265.51%923.15K
Cash from discontinued investing activities
Operating cash flow 38.02%-1.69M16.44%-8.09M27.95%-2.05M31.64%-1.5M30.49%-1.81M-34.07%-2.73M-78.09%-9.68M-42.52%-2.85M-49.91%-2.19M-117.68%-2.61M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -100.98%-62.35K006.38M-68.16K0-248.93K
Net common stock issuance ------0--0--0----------6.65M--0--0--0
Proceeds from stock option exercised by employees ------0--0--0----------52.4K--0--0--0
Net other financing activities ----80.34%-62.35K--0--0-----------317.08K---68.16K--0----
Cash from discontinued financing activities
Financing cash flow -----100.98%-62.35K--0--0----------6.38M---68.16K--0---248.93K
Net cash flow
Beginning cash position -72.49%3.09M-22.69%11.25M-63.66%5.15M-59.37%6.64M-55.65%8.52M-22.69%11.25M-27.21%14.55M-14.40%14.16M-9.18%16.36M0.03%19.21M
Current changes in cash 38.02%-1.69M-146.99%-8.15M29.63%-2.05M31.64%-1.5M34.37%-1.88M-158.45%-2.73M39.29%-3.3M-45.92%-2.92M-49.91%-2.19M-138.44%-2.86M
End cash Position -83.52%1.4M-72.49%3.09M-72.49%3.09M-63.66%5.15M-59.37%6.64M-55.65%8.52M-22.69%11.25M-22.69%11.25M-14.40%14.16M-9.18%16.36M
Free cash flow 38.02%-1.69M16.44%-8.09M27.95%-2.05M31.64%-1.5M30.49%-1.81M-34.07%-2.73M-78.09%-9.68M-42.52%-2.85M-49.91%-2.19M-117.68%-2.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data